News|Articles|September 2, 2003
- Pharmaceutical Technology-09-02-2003
- Volume 27
- Issue 9
The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride
Author(s)Kilambi Pundarikakshudu, PhD
The study presented in this article used a controlled-porosity osmotic pump, which was prepared in the form of a bilayered tablet containing a drug compartment and an osmogen layer for the delayed release of diltiazem HCI.
Advertisement
Articles in this issue
about 22 years ago
September 2003about 22 years ago
In the Spotlight September 2003about 22 years ago
Counterfeiting, Compliance, and Controlsabout 22 years ago
September 2003about 22 years ago
Disposable Filtration Lightens Cleaning and Validation Loadabout 22 years ago
CROs Hoping for Research Burst in Second Half of 2003Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
